2026 жылында Италияда жиаб-абляция жатыр миомасына бойынша ең жақсы бағалар мен клиникалар туралы біліңіз

MRgFUS is a non-invasive outpatient treatment for uterine myomas that uses high-intensity focused ultrasound pulses to destroy fibroid tissue. Guided by real-time MRI for precision, the procedure heats target cells to 60°C–85°C, causing thermal ablation while preserving the surrounding healthy uterine tissue and future fertility.

• Treatment mechanism: Ultrasound pulses cause coagulative necrosis by heating fibroids without any surgical incisions.
• MRI guidance: Real-time 3D imaging monitors tissue temperature to prevent damage to the bladder.
• Rapid recovery: Patients usually return to daily activities within 1 to 3 days post-procedure.
• Uterine preservation: The uterus remains intact, making it an alternative to hysterectomy or myomectomy.

Bookimed Expert Insight: Italian clinics specializing in women's health often integrate advanced ultrasound diagnostics with surgical expertise. For example, Ospedale Santa Maria in Bari couples ultrasound centers with major surgical departments. This allows doctors to transition patients from non-invasive FUS-ablation to robotic surgery if fibroid size exceeds 10 centimeters.

Patient Consensus: Patients value how this technology provides relief from symptoms like heavy bleeding without the risks of blood transfusions. Many appreciate avoiding general anesthesia and the ability to return home the same day.

Ideal candidates for FUS-ablation are premenopausal women with symptomatic uterine myomas who seek a non-invasive, uterus-preserving alternative to surgery. Success depends on fibroids measuring 2 to 10 cm and having low T2 signal intensity on MRI scans to ensure thermal responsiveness.

• Fibroid count: Most effective for solitary or fewer than 6 individual myomas.
• Access path: Myomas must be within 12 cm of the skin without bowel interference.
• Symptom profile: Suitable for patients experiencing heavy bleeding, pelvic pain, or urinary frequency.
• Future fertility: Preferred for women wanting to avoid hysterectomy and preserve the uterus.

Bookimed Expert Insight: While many surgical centers focus on fibroid removal, Italian clinics like Ospedale Santa Maria emphasize fertility preservation. Their Medically Assisted Procreation centers prioritize FUS-ablation specifically for patients who wish to maintain reproductive health. Italian specialists often require a high-quality MRI to confirm a subserosal or intramural location before approving this non-invasive approach.

Patient Consensus: Patients often choose this method to avoid long hospital stays and achieve a rapid return to daily life. Many emphasize that confirming fibroid size and exact location via MRI is the most important step before booking.

You can achieve pregnancy after MRgFUS because the procedure preserves healthy uterine tissue while selectively treating fibroids. Clinical studies confirm successful natural conceptions and IVF outcomes, with most patients advised to wait 3 to 6 months before conceiving to allow for proper tissue healing.

• Conception timeline: Most women conceive naturally between 8 to 12 months after the procedure.
• Birth outcomes: Research shows 41% to 72% of pregnancies after MRgFUS result in live births.
• Delivery methods: Many patients successfully achieve full-term vaginal deliveries after this non-invasive treatment.
• Fertility preservation: Unlike some alternatives, MRgFUS avoids surgical scarring and maintains ovarian function.

Bookimed Expert Insight: Italian clinics like Ospedale Santa Maria integrate FUS-ablation with established reproductive departments. Dr. Pasquale Totaro at this facility brings over 30 years of expertise in gynecology and human reproduction. Choosing a center that specializes in both fibroid ablation and infertility treatments ensures your post-procedure pregnancy plan is managed by specialists who understand how the treated tissue responds during gestation.

Patient Consensus: Patients often seek specialists in Italy who have experience managing both the ablation and subsequent fertility care. Clinical data remains the primary source of reassurance for those planning a family after treatment.

FUS-ablation of uterine myoma in Italy offers a completely non-invasive alternative to conventional myomectomy or hysterectomy. This technique uses high-intensity focused ultrasound to destroy fibroid tissue without incisions. It eliminates surgical scarring, reduces infection risks, and preserves the uterus without general anesthesia.

• Non-invasive approach: Treatment requires no surgical cuts or needles, preventing external scarring and tissue trauma.
• Organ preservation: The uterus remains intact, making it a preferred choice for future fertility goals.
• Rapid recovery: Patients typically return to normal activities within 1 to 2 days after treatment.
• High precision: Magnetic resonance imaging guides the ultrasound beams to target only the myoma tissue.

Bookimed Expert Insight: While many countries focus on laparoscopic methods, leading Italian centers like Ospedale Santa Maria specialize in reproductive health preservation. Choosing FUS-ablation here means accessing advanced thermal technology that maintains the uterine wall integrity. This is often unavailable in standard surgical facilities that only offer traditional invasive procedures.

MRgFUS for fibroids is available at specialized university clinics and private multidisciplinary centers in Italy, particularly in Rome, Milan, and Bari. This non-surgical thermal ablation uses MRI-guided focused ultrasound to target myomas while preserving the uterus without incisions or general anesthesia.

• Regional coverage: Lombardia, Lazio, and Emilia Romagna prioritize this advanced radiological technology.
• Certified facilities: Ospedale Santa Maria in Bari offers specialized gynecological ultrasound diagnostics.
• Specialized experts: Dr. Pasquale Totaro coordinates advanced obstetrics-gynecological ultrasound centers in Bari.
• Treatment focus: Clinics like Ruesch in Naples complement non-surgical options with robotic surgery.

Bookimed Expert Insight: Southern Italy is becoming a strong hub for advanced gynecology. Ospedale Santa Maria ranks first in Italy for intrauterine insemination cycles. This high volume often correlates with expertise in fertility-preserving fibroid treatments like MRgFUS.

Patient Consensus: Patients recommend contacting major teaching hospitals in Rome and Milan directly. These centers frequently lead in advanced radiology and uterine-sparing treatment options.